Markets:

Overview

News

Currencies

International

Treasuries

Masimo Corporation - Common Stock (NQ:MASI)

130.81 -0.01 (-0.01%)

Streaming Delayed Price Updated: 1:30 PM EST, Dec 30, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Masimo Corporation - Common Stock

< Previous 1 2 3 4 5 6 7 8 9

...

22 23 Next >

3 Reasons MASI is Risky and 1 Stock to Buy Instead

October 02, 2025

Over the past six months, Masimo’s shares (currently trading at $142) have posted a disappointing 17.2% loss, well below the S&P 500’s 18.4% gain. This might have investors contemplating their next...

Via StockStory

Topics Stocks

Healthcare Sector Navigates Turbulent Waters as Drug Pricing Agreements Reshape Market Landscape

September 30, 2025

September 30, 2025 – The healthcare sector today finds itself at a pivotal juncture, experiencing a complex mix of optimism and apprehension. While a landmark drug-pricing agreement between...

Via MarketMinute

Topics Artificial Intelligence Economy Government

Masimo, Integra LifeSciences, CONMED, IQVIA, and Charles River Laboratories Shares Are Soaring, What You Need To Know

September 30, 2025

A number of stocks jumped in the afternoon session after reports revealed a potential drug-pricing agreement between the White House and the pharmaceutical industry. The Trump administration is...

Via StockStory

Topics Government World Trade

Here's How Much $100 Invested In Masimo 10 Years Ago Would Be Worth Today ↗

September 29, 2025

Masimo (NASDAQ: MASI) has outperformed the market over the past 10 years by 1.12% on an annualized basis producing an average annual return of 13.99%. Currently, Masimo has a market capitalization of...

Via Benzinga

Masimo Completes Sale of Consumer Audio Business to HARMAN International

September 23, 2025

From Masimo

Via Business Wire

MASIMO INVESTIGATION INITIATED BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Investigates the Officers and Directors of Masimo Corporation - MASI

September 18, 2025

From Kahn Swick & Foti, LLC

Via GlobeNewswire

How Is The Market Feeling About Masimo? ↗

September 05, 2025

Via Benzinga

Apple’s Watch War Heats Up: Masimo Takes Customs To Court Over Blood-Oxygen Feature ↗

August 20, 2025

Via Stocktwits

Earnings Scheduled For August 5, 2025 ↗

August 05, 2025

Via Benzinga

Is the Market Bullish or Bearish on Masimo? ↗

July 24, 2025

Via Benzinga

New Study Finds That Using Masimo Technologies to Continuously Monitor General Floor Patients Reduces Costs

September 17, 2025

From Masimo

Via Business Wire

Masimo Announces Expansion of Strategic Partnership with Philips

September 11, 2025

From Masimo

Via Business Wire

3 of Wall Street’s Favorite Stocks with Questionable Fundamentals

September 02, 2025

Wall Street is overwhelmingly bullish on the stocks in this article, with price targets suggesting significant upside potential. However, it’s worth remembering that analysts rarely issue sell ratings,...

Via StockStory

Masimo to Present in the Wells Fargo Healthcare Conference

August 28, 2025

From Masimo

Via Business Wire

1 Small-Cap Stock Worth Your Attention and 2 Facing Challenges

August 27, 2025

Many small-cap stocks have limited Wall Street coverage, giving savvy investors the chance to act before everyone else catches on. But the flip side is that these businesses have increased downside...

Via StockStory

Consumer Tech News (August 18–August 22): Powell Turns Dovish As Walmart, Target Earnings Steer Sentiment, While AI Hangover Hits Palantir ↗

August 24, 2025

Powell's dovish Jackson Hole tone, mixed WMT/TGT/TJX earnings, and an AI hangover led by PLTR's slide gave way to a late-week risk rally.

Via Benzinga

Topics Artificial Intelligence

Sallie Mae, Two Harbors Investment, Flowserve, Masimo, and Select Medical Shares Skyrocket, What You Need To Know

August 22, 2025

A number of stocks jumped in the afternoon session after the major indices rebounded, as Fed Chair Jerome Powell delivered dovish remarks at the much-awaited Jackson Hole symposium. Powell suggested...

Via StockStory

Topics Economy

Apple Restores Blood-Oxygen Tracking To Watch After Customs Ruling — Masimo Strikes Back With Lawsuit Over Patent Rights ↗

August 21, 2025

Apple reintroduced blood-oxygen tracking on its watches after a Customs ruling, but Masimo has sued to block the feature again.

Via Benzinga

Topics Intellectual Property Lawsuit

Masimo O3® Regional Oximetry Receives FDA Clearance for Expanded Indication of Its Unique Delta Hemoglobin Parameters

August 19, 2025

From Masimo

Via Business Wire

3 Unprofitable Stocks That Fall Short

August 15, 2025

Running at a loss can be a red flag. Many of these businesses face mounting challenges as competition increases and funding becomes harder to secure.

Via StockStory

Apple To Reintroduce Blood Oxygen Feature On Select Watches Following Customs Ruling ↗

August 14, 2025

Apple to roll out redesigned Blood Oxygen feature for select U.S. Apple Watch models via software update, following a favorable customs ruling.

Via Benzinga

Biogen, Moderna, Align Technology, QuidelOrtho, and Masimo Shares Skyrocket, What You Need To Know

August 13, 2025

A number of stocks jumped in the afternoon session after markets continued to rally amid growing speculation of an impending interest rate cut by the Federal Reserve. Following a favorable Consumer...

Via StockStory

Topics Economy

MASI Q2 Deep Dive: Margin Expansion Amid Tariff Pressures and Strategic Leadership Changes

August 12, 2025

Medical tech company Masimo (NASDAQ:MASI) reported revenue ahead of Wall Street’s expectations in Q2 CY2025, with sales up 7.9% year on year to $370.9 million. The company expects the full year’s...

Via StockStory

Topics World Trade

Q2 Earnings Highlights: Masimo (NASDAQ:MASI) Vs The Rest Of The Patient Monitoring Stocks

August 11, 2025

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take a look at how patient monitoring stocks fared in Q2, starting with Masimo...

Via StockStory

Topics Artificial Intelligence

Masimo’s (NASDAQ:MASI) Q2: Beats On Revenue But Stock Drops

August 05, 2025

Medical tech company Masimo (NASDAQ:MASI) reported Q2 CY2025 results topping the market’s revenue expectations, with sales up 7.9% year on year to $370.9 million. The company expects the full year’s...

Via StockStory

Topics World Trade

Masimo Reports Second Quarter 2025 Results

August 05, 2025

From Masimo Corporation

Via Business Wire

Masimo (MASI) Reports Q2: Everything You Need To Know Ahead Of Earnings

August 03, 2025

Medical tech company Masimo (NASDAQ:MASI) will be reporting earnings this Tuesday afternoon. Here’s what investors should know.

Via StockStory

Topics Artificial Intelligence Economy World Trade

1 Healthcare Stock to Consider Right Now and 2 That Underwhelm

July 31, 2025

From novel pharmaceuticals to telemedicine, most healthcare companies are on a mission to drive better patient outcomes. Despite the rosy long-term prospects, short-term headwinds such as COVID...

Via StockStory

Topics Stocks

$1000 Invested In This Stock 15 Years Ago Would Be Worth This Much Today ↗

July 24, 2025

Via Benzinga

Masimo to Report Second Quarter 2025 Financial Results after Market Close on Tuesday, August 5

July 22, 2025

From Masimo

Via Business Wire

< Previous 1 2 3 4 5 6 7 8 9

...

22 23 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.